{{Rsnum
|rsid=3741298
|Gene=ZNF259
|Chromosome=11
|position=116786845
|Orientation=minus
|GMAF=0.3255
|Gene_s=ZNF259
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 65.5 | 31.9 | 2.7
| HCB | 37.2 | 49.6 | 13.1
| JPT | 18.6 | 52.2 | 29.2
| YRI | 47.6 | 44.2 | 8.2
| ASW | 50.9 | 45.6 | 3.5
| CHB | 37.2 | 49.6 | 13.1
| CHD | 35.8 | 51.4 | 12.8
| GIH | 51.5 | 41.6 | 6.9
| LWK | 43.6 | 40.9 | 15.5
| MEX | 34.5 | 50.0 | 15.5
| MKK | 44.9 | 48.7 | 6.4
| TSI | 54.9 | 32.4 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21889769
|Title=Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}